Previous Article | Next Article 
J Bacteriol, June 1998, p. 3080-3090, Vol. 180, No. 12
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Preparation and Characterization of Neisseria
meningitidis Mutants Deficient in Production of the Human
Lactoferrin-Binding Proteins LbpA and LbpB
Robert A.
Bonnah and
Anthony B.
Schryvers*
Department of Microbiology and Infectious
Diseases, University of Calgary, Health Sciences Center, Calgary,
Alberta, Canada T2N 4N1
Received 13 January 1998/Accepted 29 March 1998
 |
ABSTRACT |
Pathogenic members of the family Neisseriaceae produce
specific receptors facilitating iron acquisition from transferrin (Tf) and lactoferrin (Lf) of their mammalian host. Tf receptors are composed
of two outer membrane proteins, Tf-binding proteins A and B (TbpA and
TbpB; formerly designated Tbp1 and Tbp2, respectively). Although only a
single Lf-binding protein, LbpA (formerly designated Lbp1), had
previously been recognized, we recently identified additional bacterial
Lf-binding proteins in the human pathogens Neisseria
meningitidis and Moraxella catarrhalis and the bovine pathogen Moraxella bovis by a modified affinity isolation
technique (R. A. Bonnah, R.-H. Yu, and A. B. Schryvers,
Microb. Pathog. 19:285-297, 1995). In this report, we characterize an
open reading frame (ORF) located immediately upstream of the
N. meningitidis B16B6 lbpA gene. Amino
acid sequence comparisons of various TbpBs with the product of the
translated DNA sequence from the upstream ORF suggests that the region
encodes the Lf-binding protein B homolog (LbpB). The LbpB from strain
B16B6 has two large stretches of negatively charged amino acids that
are not present in the various transferrin receptor homologs (TbpBs).
Expression of the recombinant LbpB protein as a fusion with maltose
binding protein demonstrated functional Lf-binding activity. Studies
with N. meningitidis isogenic mutants in which the
lbpA gene and the ORF immediately upstream of
lbpA (putative lbpB gene) were insertionally
inactivated demonstrated that LbpA, but not LbpB, is essential for iron
acquisition from Lf in vitro.
 |
INTRODUCTION |
Elemental iron is essential for the
sustained growth of nearly all living organisms. When infecting their
mammalian host, invading microbes are confronted with an environment
with iron levels far too low to permit their proliferation. The iron
stores of the host are primarily intracellular, and extracellular iron in serum and cerebrospinal fluid is bound by the glycoprotein transferrin (Tf), whereas the glycoprotein lactoferrin (Lf) serves to
sequester iron on mucosal surfaces. To attain iron, many microbes produce and secrete siderophores, small molecules which are able to
chelate both soluble and insoluble environmental iron. The resulting
iron-siderophore complex is subsequently bound at the bacterial cell
surface by a specific receptor and then transported to the periplasmic
region of the cells, where it can be shuttled to the cytoplasm for
storage and utilization (15, 32).
Some bacteria do not produce siderophores but acquire iron by
alternative mechanisms that are seemingly advantageous in their ecological niche. Pathogenic organisms such as the strict human pathogens Neisseria meningitidis (45, 47),
Neisseria gonorrhoeae (28), Moraxella
(Branhamella) catarrhalis (10-12,
45), and Moraxella lacunata (11, 34) and
the bovine pathogen Moraxella bovis (10) have
been shown to possess host Tf- and Lf-specific receptors to circumvent
the iron sequestration of the host (see reference 21
for a review of this mechanism of iron acquisition). Thus, capture of
iron from these host iron-binding glycoproteins permits proliferation
of these organisms in an otherwise iron-restricted environment.
There are two outer membrane components of the receptor-mediated
mechanism of iron acquisition: Tf-binding proteins A and B (TbpA and
TbpB). Although only a TbpA functional homolog was described for the Lf
receptor (LbpA) (37, 39), recent genetic (36, 38)
and biochemical (10, 12) evidence implies that bacterial Lf
receptors have a second constituent (LbpB) with attributes comparable
to those of TbpB.
The objective of this study was to examine the role of
N. meningitidis LbpA in iron acquisition
from Lf and characterize an open reading frame (ORF) located
immediately upstream of the lbpA structural gene which has
significant sequence homology to the B component of the bacterial Tf
receptor (putative lbpB gene). For this purpose, we have
prepared a series of isogenic mutants which lack either or both Lf
receptor proteins. Given that the Tf receptor proteins characterized to
date appear to have an operonic organization (21), we also
address the possibility that LbpA and LbpB are cotranscribed and
perform preliminary biochemical characterization of the proteins
encoded by both ORFs.
 |
MATERIALS AND METHODS |
Growth conditions, bacterial strains, and plasmids.
Neisseria and Moraxella sp. cells were propagated
in brain heart infusion (BHI) media, whereas Escherichia
coli strains were cultured in L broth. Iron starvation of
bacterial cells (46) and preparation of crude membranes were
achieved as specified previously (45). Growth studies were
performed by in vitro plate assays described previously (10)
in which BHI agar plates containing 100 µM
ethylenediamine-di(o-hydroxyphenylacetic acid) (EDDA) were examined after 24 and 48 h of incubation for cell growth
surrounding the disks containing 200 µg of iron-loaded Lf or Tf.
N. meningitidis B16B6 and its derivatives N16T1E
(tbpA::erm), N16T2K
(tbpB::kan), and N16T12EK
(tbpB::kan
tbpA::erm) have been described previously (24). Plasmid pAM23, which contains a functional copy of the lbpA gene from N. meningitidis BNCV
(37), was provided by J. Tommassen, University of Utrecht
(Utrecht, The Netherlands). The lbp genes were insertionally
inactivated by using either a chloramphenicol acetyltransferase gene
with a transcriptional terminator (cat
) (26)
or a gentamicin resistance cassette (gent) (48)
provided by H. Schweizer, Colorado State University (Boulder). The
pMal-c2 vector (which lacks the normal signal sequence of the
malE gene) and the amylose affinity resin were purchased
from New England BioLabs (Mississauga, Ontario, Canada). All enzymes
and growth media were purchased from Gibco BRL (Burlington, Ontario,
Canada), whereas chemical reagents were purchased from Sigma (St.
Louis, Mo.), unless otherwise indicated.
Protein analysis.
The high-stringency solid-phase binding
assay using horseradish peroxidase (HRP)-labeled human Tf (Jackson
Immunoresearch Laboratories, West Grove, Pa.), human Lf, or bovine Tf
has been described previously (10), except that Tf-binding
assays were routinely performed with 50 mM Tris buffer (pH 8.0),
containing 1 M NaCl, whereas the Lf-binding assays were performed in
the same buffer, at pH 9.0. Alternatively, where indicated, binding assays were performed in low-pH, low-stringency buffer containing 50 mM
Tris-HCl (pH 6.0) plus 0.1 M NaCl to enhance LbpB-Lf interactions (10). Covalent linkage of Tf or Lf to cyanogen bromide
(CNBr)-activated CH Sepharose 4B (Pierce Chemical, Rockford, Ill.) or
HRP was performed as described previously (33). Prevention
of nonspecific binding to either Nitro ME-nitrocellulose (Micron
Separations, Westboro, Mass.), used for solid-phase binding assays, or
to Immobilon P (Millipore, Bedford, Mass.), used for Western blot
analysis, was achieved by using blotting-grade nonfat dry milk blocker,
whereas color development was performed with HRP development reagent, which was purchased from Bio-Rad (Richmond, Calif.).
For sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), samples were boiled in Laemmli sample buffer unless otherwise indicated, separated by using a 10% acrylamide gel and the
Tris-HCl-glycine buffer system (27), and then transferred to Immobilon P (Western blot) and probed with specific antisera, as
described previously for Lbps (10). Protein concentrations were determined by the Bio-Rad DC protein assay.
DNA manipulations.
PCR was employed to amplify specific
regions of plasmid or chromosomal DNA from E. coli or
N. meningitidis strains. For PCR screening,
supernatants from boiled bacterial colonies suspended in small aliquots
of sterile water were used as a template. Microscale purification
of bacterial chromosomal DNA was performed as described previously (6), whereas the Promega (Madison, Wis.) Wizard Plus miniprep system was used to isolate plasmid DNA.
Electrophoretically separated DNA fragments were purified by using the
QIAquick gel extraction kit (Qiagen, Hilden, Germany). For
Southern blot analysis (4), the PCR digoxigenin labeling mix
was used to label DNA probes (Boehringer GmbH, Mannheim, Germany).
Determination of the N. meningitidis B16B6
lbpB gene sequence.
To delineate the DNA sequence of
regions upstream of lbpA, ligation-based PCR was performed
(see Fig. 1). Briefly, after Southern hybridization was used to map the
region upstream of N. meningitidis B16B6
lbpA, chromosomal DNA was linearized with XbaI
(Fig. 1) (2.6 kb upstream of the lbpA start site). Separated
DNA fragments of the preferred size were excised from the agarose gel,
purified, and ligated to XbaI-linearized pT7 vector. The
ligation mixture was used in a standard PCR with the T7 primer and an
lbpA-specific primer. Both strands of the PCR product were
sequenced directly (University of Calgary Core DNA Services Laboratory)
by using a Taq Dye Deoxy Terminator Cycle Sequencing Kit
(Applied Biosystems, Foster City, Calif.) with a series of sequencing
primers (Table 1) and analyzed with the
ABI Sequence Editor program. DNAsis (Hitachi Software) and Gene
Construction Kit software (Textco, Inc.) were used for analysis of DNA
sequence data and determination of ORFs, protein molecular weights, or
isoelectric points. Images were scanned with a Hewlett-Packard
ScanJet IIp, with accompanying DeskScan software, imported
into Adobe Photoshop for manipulation, and then subsequently labeled by
using MacDraw Pro.
Construction of N. meningitidis isogenic
mutants.
To insertionally inactivate the lbpB gene, a
gent cassette with flanking ClaI sites was
subcloned into the ClaI site of the partial lbpB
gene (see Fig. 3A). In addition, a cat
resistance determinant was ligated into the SalI site of the cloned
(pCR2.1) full-length lbpB gene (see Fig. 3B), as well as the
EagI site of the strain BNCV lbpA gene on plasmid
pAM23, to insertionally inactivate the lbpA gene.
For biosafety concerns (introduction of the cat gene),
N. meningitidis N16T12EK (24), a
strain B16B6 derivative which lacks both TbpA and TbpB and is unlikely
to proliferate in humans (14), was chosen as a host strain
for gene replacement. DNA was linearized and then introduced into
strain N16T12EK by either natural transformation (lbpB::cat
or
pAM23::cat
plasmids) (49) or
electroporation (lbpB::gent)
(43) with a Bio-Rad Gene Pulser and standard parameters. Transformants were selected on BHI agar with appropriate antibiotic selection.
LbpB and LbpA expression and isolation.
To prepare
Mbp::LbpB fusion protein, we used N. meningitidis B16B6 DNA as a template with primers 591 and 539 (Table 1) to amplify the lbpB gene lacking the region
encoding the signal peptide, as well as the signal peptidase II
recognition site and N-terminal Cys. Primer 591 incorporated an
XmnI site immediately upstream of the region coding for
mature LbpB protein to allow in-frame ligation to the malE
gene of pMal-c2. Expression of Mbp::LbpB fusion protein was
induced by the addition of
isopropyl-
-D-thiogalactopyranoside (IPTG) to E. coli DH5
cells containing the pMal-c2lbpB plasmid in
accordance with the supplier's instructions.
For expression of the full-length LbpB, the strain B16B6
lbpB gene was amplified by PCR using oligonucleotide primers
536 and 539 (Table 1). Primer 536 was specific for the predicted native
5'-end lbpB gene, with an NdeI site incorporated
immediately upstream of the ATG start codon to facilitate direct
cloning into the pT7 expression system (50, 51). Primer 539 was specific for the noncoding strand of the N. meningitidis BNCV lbpA gene (37, 39) at a
region which encodes the mature N terminus of LbpA.
Prior to ligation into pT7, the N. meningitidis BNCV
lbpA (iroA) gene from plasmid pAM23 (37,
39) was modified by using overlapping oligonucleotide primers 218 and 219 (Table 1). In successive PCRs, the native NdeI site
was eliminated and an NdeI site was incorporated immediately
upstream of the lbpA ATG start codon (confirmed by sequence
analysis) to facilitate ligation to pT7. Expression of the pT7
derivatives (pT7lbpB and pT7lbpA) was achieved by
addition of CE6 bacteriophage as described previously (50).
Mbp::LbpB isolation was achieved by lysing cells with a
French press, removing cellular debris by centrifugation, and then using the supernatant for affinity purification with amylose resin as
described previously (4). LbpA from N. meningitidis B16B6 was affinity purified by using standard
high-stringency affinity isolation conditions described previously,
with human Lf-Sepharose as the affinity matrix (10).
Antiserum production.
Rabbit polyclonal antiserum specific
for either Mbp::LbpB or LbpA was generated by standard
techniques in female New Zealand White rabbits. Briefly, 50 µg of
purified protein emulsified in complete Freund's adjuvant was given by
intramuscular injection. Subsequent subcutaneous booster injections
containing the same dose of protein antigen emulsified in incomplete
Freund's adjuvant were performed at 17 and 30 days after the primary
injection, and sera were collected 1 week later.
 |
RESULTS |
Analysis of DNA nucleotide sequence upstream of lbpA.
Limited DNA sequence information suggested that a putative ORF with
corresponding amino acid sequence homology to TbpB may reside upstream
of the N. meningitidis lbpA gene (36). Thus, we sought to characterize and determine the role of the putative upstream ORF in iron acquisition from human Lf. Due to difficulties encountered when directly cloning the tbpB gene from several
bacterial species, we were inclined to utilize an approach that would
avoid these problems. One solution was to utilize ligation-based PCR (Fig. 1) to amplify genetic elements
adjacent to known DNA sequences. By PCR amplification of regions
upstream of the lbpA gene, we could sequence the PCR product
directly and avoid anticipated difficulties in cloning the DNA
elements.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Southern hybridization map of the N. meningitidis B16B6 lbpA upstream region and
diagrammatic representation of ligation-based PCR protocol. A genetic
map of the regions immediately upstream of the N. meningitidis B16B6 lbpA gene (lbpA start is
indicated) was determined by Southern hybridization analysis using an
lbpB-specific DNA probe (36). Ligation-based PCR
was used to amplify the region upstream of lbpA. Depicted is
a single-step ligation-based PCR protocol in which the chromosomal DNA
from N. meningitidis B16B6 was digested with
XbaI (XbaI site situated approximately 2.6 kb
upstream of lbpA start) and ligated to
XbaI-linearized pT7 vector. The ligated fragments were used
as templates in a PCR using the T7 primer and an
lbpA-specific primer. Scale is in base pairs.
|
|
We utilized a ligation-based PCR strategy to amplify 2.6 kb upstream of
the strain B16B6 lbpA gene, and the PCR product was sequenced (see Materials and Methods). Analysis of the DNA sequence upstream of the N. meningitidis B16B6 lbpA
gene (GenBank accession no. AF031432) revealed a large putative ORF,
encoding either 739 (ORF1a) or 726 (ORF1b) amino acids, depending on
which ATG start codon was considered authentic. We suspect that the
second start codon (ORF1b) is authentic since it has an appropriately positioned ribosomal binding site and promoter region, which is in
contrast to the first putative lbpA start codon. In
addition, the ORF1b product possesses a hydrophobic signal peptide or
preprotein peptide of 18 amino acids with significant homology to that
of lipoproteins posttranslationally modified by the addition of fatty acyl chains to their N-terminal Cys residues before cleavage by signal
peptidase II (53).
Compared to E. coli promoter DNA sequences (23),
ORF1b has 5 of 6 and 6 of 6 identical bases at the
35 and
10
regions, respectively, and exactly 17 bases between the two sites,
reflecting a conserved interaction with RNA polymerases
(23). Also, a putative Fur box (ferric uptake regulation)
with 16 of 19 bases identical to consensus sequences (5)
overlaps with the proposed
10 region. In addition, two nearly
identical stretches of DNA sequence found either upstream or downstream
from a number of meningococcal and gonococcal genes were identified. No
known function has been attributed to this sequence; however, its
presence upstream, or in some cases downstream, of Neisseria
structural genes suggests a potential role in genetic recombinational
events.
Amino acid sequence comparison of LbpB and TbpB.
The predicted
amino acid sequence of N. meningitidis B16B6 LbpB was
aligned with those of known TbpB proteins (Fig.
2). Sequences of TbpB from N. meningitidis B16B6 (GenBank accession no. Z15129) and M982
(Z15130) (29), N. gonorrhoeae FA19 (U05205)
(2), Haemophilus influenzae DL63 (U10882)
(20), Actinobacillus pleuropneumoniae S-tp1
(Z46775) (18) and H49 (U16017) (19), and
Pasteurella haemolytica H196 (U73302) (35)
were used in this analysis. Several regions of amino acid sequence identity between all TbpBs and LbpB were found (Fig. 2). The
708-amino-acid mature LbpB protein from strain B16B6 differed from all
TbpB homologs in two distinct areas which contained one large
stretch and one smaller stretch of negatively charged amino acids
(Fig. 2). Amino acids 434 to 515 (QDEED...RDID) contained only 6 positively charged residues (1 Arg, 4 Asn, and 1 Gln) but 39 negatively
charged residues (13 Asp and 26 Glu). A second negatively charged
region encompassing amino acids 675 to 700 (Fig. 2) (EGTEN...DADVE)
contained only 2 positively charged residues (1 Arg and 1 Lys) and 13 negatively charged residues (8 Asp and 4 Glu). It is interesting to
note that the negatively charged regions were both localized to the C-terminal portion of LbpB. In addition, a poorly conserved region speculated to be a phosphate-binding loop (P-loop motif) for TbpB (30) is shown (Fig. 2).

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of the putative N. meningitidis LbpB protein sequence with sequences of TbpB proteins
from related organisms. The putative amino acid sequence of
N. meningitidis B16B6 LbpB was compared to the known
amino acid sequences of other known TbpBs, namely, N. meningitidis B16B6 and M982 (29), N. gonorrhoeae FA19 (2), A. pleuropneumoniae
H49 (19) and S-tp1 (18), P. haemolytica H196 (35), and H. influenzae
DL63 (20). The basic alignment was performed by using the
program DNAsis. *, homology with at least three other TbpBs; ,
absolute homology with all selected TbpBs. Shaded boxes indicate
negatively charged regions of LbpB not present in TbpBs; unshaded box
indicates proposed site of P-loop motif.
|
|
Construction of N. meningitidis mutants and
confirmation of gene replacement.
As a first step in
characterizing the roles of LbpA and LbpB in iron acquisition from Lf,
we constructed isogenic mutants lacking either or both receptor
proteins. We interrupted the reading frames of the cloned
lbpA and lbpB genes with antibiotic resistance cassettes (insertional inactivation) (Fig.
3) conferring resistance to either
gentamicin (gent) or chloramphenicol (cat
).
Appropriate antibiotic selection was used to initially identify clones
in which the mutated DNA had undergone homologous recombination with the native gene. For biosafety considerations, we used a previously described N. meningitidis B16B6 mutant (strain
N16T12EK) (24) which was deficient for both of the Tf
receptor proteins, TbpB and TbpA
(tbpA::mTn3erm and
tbpB::kan), as a recipient host strain to introduce the mutated lbpA and lbpB genes.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
(A) Construction of an N. meningitidis
N16T12EK lbpB::gent isogenic mutant.
The lbpB gene was amplified by PCR using primers 513 and 215 and cloned into pCR2.1. A gentamicin (gent) resistance
marker with flanking ClaI sites was ligated into the unique
ClaI site. An E. coli colony was isolated with
the gent cassette in the orientation opposite to that of the
lbpB reading frame (determined by PCR analysis). The DNA was
linearized by using unique restriction enzymes sites in the pCR2.1
polylinker sequence, and the DNA was electroporated into N. meningitidis N16T12EK (TbpB TbpA ). (B)
Construction of N. meningitidis N16T12EK
lbpB::cat and
lbpA::cat isogenic mutants. The
entire N. meningitidis B16B6 lbpB gene was
amplified by PCR using primers 536 and 539 and cloned into pCR2.1. A
chloramphenicol acetyltransferase omega (cat ) resistance
marker with flanking SalI sites was ligated into the unique
SalI site of the B16B6 lbpB gene, and the
cat with flanking EagI sites was ligated into
the unique EagI site of the strain BNCV lbpA gene
(37). Orientation of the inserted cat gene was
determined by PCR analysis. The DNA was linearized by using
NdeI sites that flanked the DNA inserts and used for natural
transformation into N. meningitidis N16T12EK. The
NdeI site at the 5' end of the B16B6 lbpB gene
was incorporated by using site-specific mutagenesis with primer 536 (Table 1). The gent and cat cassette
insertions are as shown. The cat cassette was inserted in
the orientation opposite to that of the lbpA gene.
|
|
PCR amplifications with primers specific for the gent gene,
the cat gene, and the lbpB and lbpA
genes, adjacent to the sites of insertion, were used to verify the
identity of the isogenic mutants. Primers flanking the ClaI
site (primers 513 and 539) (Table 1; Fig. 3A) in lbpB
amplified a 1.35-kb PCR product from the parental strain N16T12EK (Fig.
4, lane 1) as well as the
lbpB::cat
(lane 3) and
lbpA::cat
(lane 4) mutant
derivatives. In the lbpB::gent mutant,
a 2.6-kb PCR product was obtained, consistent with insertion of the
1.35-kb gentamicin resistance determinant into the ClaI site. As further proof of gene replacement of the native
lbpB gene with lbpB::gent,
we used a primer specific for the region encoding the C terminus of the
gent cassette (primer 262) and a primer specific for the
noncoding strand of the signal peptide region of the lbpA
gene (primer 539) and obtained a 1.7-kb PCR product with the
lbpB::gent mutant (lane 13),
demonstrating that the gent cassette was in the opposite
orientation of the lbpB gene. We were unable to
amplify a PCR product with the B16B6 wild-type strain,
strain N16T12EK, or with the N16T12EK
lbpB::cat
and
lbpA::cat
mutants by using this
primer pair (data not shown).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
PCR analysis. Gentamicin-resistant or
chloramphenicol-resistant N. meningitidis B16B6
colonies were selected for PCR analysis, and PCR products were
separated by electrophoresis. Products in lanes 1 to 4 were obtained
with primers 513 and 539 (Table 1), which flank the ClaI
site of the lbpB gene. Products in lanes 5 to 8 were
obtained with primers 536 and 537, which flank the unique
SalI site of the lbpB gene. Lanes 9 to 12 were
obtained with primers 287 and 212, which flank the EagI site
of the meningococcal lbpA gene (39). The PCR
product in lane 13 was obtained with primer 262, which is specific for
the 5' end of the gent cassette, and primer 539, which is
specific for the lbpA gene (39). Lane 14 contains
the PCR product obtained with primer 536, which is specific for the 5'
end of the lbpB gene, and primer 395, which is specific for
the 3' end of the cat gene (22). The PCR
product in lane 15 was obtained with primers 287 and 394, which are
specific for regions upstream of the 3' end of the cat
gene (22). Lanes 1, 5, and 9, N16T12EK; 2, 6, 10, and 13, N16T12EK lbpB::gent; 3, 7, 8, and 14, N16T12EK lbpB::cat ; 4, 8, 12, and
15, N16T12EK lbpA::cat . A negative
image of the ethidium bromide-stained agarose gel is shown. STDS,
molecular weight standards.
|
|
Primers flanking the SalI site of the lbpB gene
(Fig. 3B) were used to verify the identity of the
lbpB::cat
mutants. By using primers
536 and 537 (Table 1), a 0.95-kb PCR product was obtained with the
parental strain N16T12EK (Fig. 4, lane 5) and the
lbpB::gent (lane 6) and
lbpA::cat
(lane 8) mutants that were
unaffected at this region of the lbpB gene. In contrast, a
2.4-kb product was obtained with the
lbpB::cat
mutant (lane 7),
consistent with insertion of the SalI cat
cassette (1.5 kb). In addition, by using primer 536 and a primer
specific for the C terminus of the cat cassette (primer
395), we amplified a 2.1-kb PCR product from the
lbpB::cat
mutant (lane 14), which
accounts for the insertion of the 1.5-kb cat
gene in the
same orientation as the lbpB gene. PCR products were not
obtained with either the lbpB::gent or
lbpA::cat
N16T12EK derivatives (data
not shown) by using this primer pair.
By using primers 287 and 212, which flank the EagI insertion
site of the cat
cassette in the lbpA gene
(Fig. 3B; Table 1), a 0.67-kb PCR product was obtained with strain
N16T12EK (Fig. 4, lane 9) and with the
lbpB::gent (lane 10) and
lbpB::cat
(lane 11) N16T12EK
derivatives which were unaffected at this region of the lbpA
gene. In contrast, a 2.0-kb PCR product was obtained with the N16T12EK
lbpA::cat
mutant (lane 12), which
accounts for insertion of the 1.3-kb cat
cassette into
the EagI site of the lbpA gene. In addition, by
using primer 287 and a primer specific for regions upstream of the 5'
end of the cat
cassette (primer 394), we were able to
amplify a 1,572-bp PCR product from the N16T12EK
lbpA::cat
mutant (lane 15),
demonstrating that the cat
cassette had been inserted in
the orientation opposite to that of the reading frame of the
lbpA gene. No PCR products were obtained with strain
N16T12EK or the lbpB::gent or
lbpB::cat
derivatives when this
primer pair was used (data not shown).
Western blot analysis of mutants.
To demonstrate that the
insertionally inactivated lbpB mutants did not produce
truncated LbpB, we prepared Western blots of the separated total
cellular proteins from the individual mutants which were probed with
Mbp::LbpB-specific polyclonal antisera. A single 85-kDa
protein was detected in both the parental strain (Fig.
5) and the
lbpA::cat
mutant. In contrast, LbpB
was not detected in either the
lbpB::gent mutant or the
lbpB::cat
mutant (Fig. 5).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 5.
Western blot analysis of N. meningitidis
mutants. N. meningitidis cells that were grown under
iron-limiting conditions to similar optical densities were boiled in
Laemmli sample buffer prior to SDS-PAGE and Western blotting. The blots
were blocked and incubated with rabbit polyclonal antisera specific for
Mbp::LbpB. Binding of the rabbit polyclonal antibodies was
detected by using anti-rabbit antibody-HRP conjugate and developed.
|
|
Characterization of mutants.
To evaluate the ligand-binding
properties of the isogenic mutant strains, we used a solid-phase
binding assay (10). Lysates of cells grown in iron-deficient
media were spotted onto nitrocellulose, incubated with HRP-labeled
human Lf or human Tf under either high- or low-stringency buffer
conditions (see Materials and Methods), and then developed. The
low-stringency conditions were used because they are necessary for
detection of Lf interactions with LbpB (10). As mentioned
previously, the parental meningococcal strain used for introduction of
the insertionally inactivated lbpB and lbpA genes
(strain N16T12EK) was deficient in the production of both TbpB
(tbpB::kan) and TbpA
(tbpA::mTn3erm) and can neither bind (Fig. 6) nor utilize Tf (Table
2) as a sole iron source (24).
Additional control meningococcal strains deficient in the
production of either TbpA (strain N16T1E;
tbpA::mTn3erm) or TbpB (strain N16T2K;
tbpB::kan) (24)
were also included in our analysis to compare and contrast the Tf- and
Lf-binding properties of the mutants lacking the individual receptor
proteins (Fig. 6).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of binding of various mutants to Lf- and Tf-HRP
conjugates. Equal amounts of lysed cell suspension obtained from
bacteria grown under iron-restricted conditions were spotted directly
onto nitrocellulose membranes (in triplicate). After blocking, the
blots were incubated in either high-stringency Tf-binding buffer (50 mM
Tris, 1 M NaCl [pH 8.0]), high-stringency Lf-binding buffer (50 mM
Tris, 1 M NaCl [pH 9.0]), or low-stringency Lf-binding buffer (50 mM
Tris, 0.1 M NaCl [pH 6.0]), containing 1:1,000 dilutions of
peroxidase-conjugated human Lf (hLf-HRP) or human Tf (hTf-HRP). After
repeatedly being washed in the binding buffer, the blots were
subsequently developed. The N. meningitidis
TbpA and TbpB mutants used as controls have
been characterized previously (24).
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Ability of various defined mutants to utilize human Lf
and Tf as a sole iron source and production of Lf or Tf
receptor proteins
|
|
In accordance with previous results with an N. meningitidis B16B6 lbpA::gent
mutant, (11) strain N16T12EK
lbpA::cat
displayed no evident
binding to human Lf-HRP when the high-stringency solid-phase binding
assay was used (Fig. 6). This implies that the Lf-binding activity
displayed under these assay conditions can be attributed solely to
LbpA, as suggested previously (10). In contrast to the
lbpA::cat
mutant, the
tbpA::erm mutant (strain N16T1E)
displayed some Tf-binding activity, under high-stringency conditions
(Fig. 6). We subsequently examined the Lf-binding properties of the N16T12EK lbpA::cat
mutant under
the low-stringency conditions and were able to detect weak Lf binding
that is attributable to the additional Lf-binding protein (LbpB). The
absence of this Lf-binding activity with the N16T12EK
lbpB::cat
mutant confirms that this
binding activity is not due to nonspecific interactions by the cells
under the low-stringency assay conditions.
The binding activities of the two LbpB
mutants
(lbpB::gent and
lbpB::cat
) are clearly different
under high- and low-stringency conditions (Fig. 6). Since the binding
activity under high-stringency conditions is solely attributable to
LbpA, the results illustrate that insertion of the gent
cassette into the lbpB gene reduces, but does not eliminate,
Lf-binding activity by LbpA. Similar results were obtained when the
N. meningitidis tbpB gene was insertionally inactivated
with a kan cassette (strain N16T2K; TbpB+),
where binding to human Tf-HRP was also dramatically impaired relative
to that of the wild type (Fig. 6). In contrast, the
lbpB::cat
insertion mutant, which contains a
transcriptional terminator, completely eliminates Lf-binding activity
under either high- or low-stringency assay conditions.
Growth analysis of N. meningitidis mutants.
The defined mutants were examined for their ability to utilize various
iron sources by using a previously described plate growth assay
(10); in this assay, iron-starved organisms were spread onto
BHI media containing an iron chelator and sterile disks containing the
individual iron sources were placed on the media to allow localized
diffusion. Strain B16B6 (wild type) and the bovine pathogen M. bovis served as controls for utilization of iron from human and
bovine forms of Lf and Tf. Under these assay conditions, growth of
M. bovis was observed only when bovine Lf or Tf, and not
human Lf or Tf, was provided as an iron source (data not shown). In
contrast to strain B16B6, strain N16T12EK (TbpB
TbpA
) and derivatives of this strain
(lbpB::gent,
lbpB::cat
, and lbpA::cat
) were unable to grow when
human Tf was supplied as the sole iron source (Table 2).
When we tested the meningococcal
lbpA::cat
derivative of
strain N16T12EK, we did not observe any growth of this
TbpB
TbpA
LbpA
meningococcal
mutant surrounding the human Lf-impregnated disk (Table 2). This data
supports the conclusion that the TonB-dependent membrane-spanning
constituent of the bacterial Lf receptor (LbpA) is essential for
utilization of iron bound to Lf, as demonstrated previously (11,
37, 40). Similarly, the N16T12EK
lbpB::cat
mutant displayed no
detectable growth when human Lf was supplied as the sole iron
source, consistent with the lack of LbpA produced in this
strain. A small intense zone of growth surrounding the human
Lf-impregnated disk (approximately 1.0 to 1.5 mm in diameter) was
observed with the N16T12EK lbpB::gent
mutant (TbpA
TbpB
LbpB
),
suggesting that this mutant retains the capacity to utilize Lf,
provided that the iron source is present in a sufficiently high
concentration. In contrast, the zones of growth surrounding the human
Lf-impregnated disks for strain B16B6 and strain N16T12EK (TbpA
TbpB
) appeared as disperse areas of
growth (approximately 4 to 5 mm in diameter), presumably indicative of
the ability to use Lf at lower concentrations.
Recombinant LbpA and LbpB analysis.
In view of prior
difficulties in cloning the tbpB structural gene and
upstream regions from N. meningitidis, we designed PCR primers (Table 1) that would allow amplification of the entire coding
sequence of the lbpB and lbpA genes, lacking the
putative ribosomal binding site and promoter. As well, we included
NdeI sites at the start codons to facilitate subcloning into
pT7-7 (50) for controlled expression of recombinant LbpB.
Ligation of the lbpA gene into pT7 necessitated the removal
of an NdeI site located 70 bases downstream of the
lbpA gene ATG start codon (37) (see Materials and
Methods). PCR products were ligated into pCR2.1, and then the gene
products of modified lbpB and lbpA genes were
subcloned in the pT7 vector
(NdeI/HindIII), transformed into a
nonexpression host (E. coli DH5
), and expressed by
the addition of CE6 bacteriophage as described previously
(50). For production of recombinant LbpB that could be
readily purified, we prepared oligonucleotide primers (primers 591 and
539) (Table 1) to allow PCR amplification of the region encoding the
mature LbpB lacking the N-terminal cysteine. The resulting PCR product was subcloned into the pMal-c2 vector for production of
Mbp::LbpB fusion protein. It has been previously demonstrated
that stable Mbp::TbpB fusions produced in E. coli
retained salient characteristics of native TbpB (41).
To evaluate the expression of the recombinant proteins, samples of
induced whole cells were boiled in Laemmli sample buffer, subjected to
SDS-PAGE, electroblotted, and detected with appropriate antisera.
Expression of LbpA (Fig. 7, lane 2) was
detected in the CE6-infected E. coli pT7lbpA
cells with LbpA-specific polyclonal antisera, whereas no protein was
detected in uninfected cells (lane 1). Similarly, expression of LbpB
was detected only in CE6-infected E. coli pT7lbpB
cells by using Mbp::LbpB-specific polyclonal antisera (compare lanes 3 and 4). The same antisera detected production of
Mbp::LbpB in E. coli pMal-c2lbpB cells
with both IPTG-induced (lane 6) and uninduced (lane 5) cells; however,
the uninduced cells produced considerably less fusion protein. It is
interesting to note that the quantity of recombinant fusion protein
present in IPTG-induced E. coli pMal-c2 cells was
considerably greater than the LbpB produced with the phage-infected
E. coli pT7lbpA and pT7lbpB cells as
detected by Coomassie blue staining of the gels (data not shown) or
serological analysis of the electroblotted proteins (Fig. 7; compare
lanes 6 and 7 and lanes 2 and 4). It is important to note that
considerable amounts of degradation products were seen in all of the
E. coli cells producing recombinant Lbps (Fig. 7, lanes 2, 4, 6, and 7).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 7.
Western blot analysis of recombinant LbpB and LbpA.
E. coli cells with the meningococcal lbpA
(lanes 1 and 2) or lbpB (lanes 3 and 4) gene under
control of the T7 promoter were either infected (+phage) with CE6
phage or uninfected ( phage). E. coli cells with the
pMal-c2lbpB plasmid (lanes 5, 6, 7, and 10) were either
induced (+IPTG) or left uninduced ( IPTG). The IPTG-induced cells with
pMal-c2lbpB were subjected to affinity isolation using
immobilized amylose. Specifically bound proteins were eluted by the
addition of 10 mM maltose and lyophilized. The collected cells (lanes 1 to 7 and 10) or isolated Mbp::LbpB fusion protein (lanes 8 and 9) was then incubated with Laemmli sample buffer and either boiled
(lanes 1 to 7) or left unboiled (lanes 8 to 10) and subjected to
SDS-PAGE. The gel was either stained for protein (lane 8 only) or
Western blotted. For serological detection of proteins, the blot was
first incubated with a 1:5,000-diluted rabbit polyclonal antiserum
raised against (i) B16B6 LbpA (lanes 1 and 2), (ii) Mbp::LbpB
(lanes 3 to 6), or (iii) MBP (lane 7). The blots were washed, incubated
in the presence of goat anti-rabbit-HRP immunoglobulin G, and
developed. Alternatively, the blots were incubated in the presence of
50 mM Tris-0.10 M NaCl (pH 6.0) containing human Lf-HRP (lanes 9 and
10) and then washed and developed. Symbols indicate LbpA ( ),
LbpB ( ), and
proteins with molecular masses of 123 ( ), 95 (&atyp0220;), and 85 ( ) kDa.
|
|
The Mbp::LbpB was affinity purified by using amylose resin,
and the maltose-eluted fraction was incubated without boiling in
Laemmli sample buffer and separated by SDS-PAGE. The gel was either
stained for protein (Fig. 7, lane 8) or electrophoretically transferred
to Immobilon-P (Western blot; see below). The Coomassie-stained gel of
the isolated samples (Fig. 7, lane 8) revealed that the majority of
protein isolated had an approximate molecular mass of 123 kDa; however,
significant quantities of two additional proteins with approximate
molecular masses of 95 and 85 kDa were also isolated.
Western blots of the affinity-isolated Mbp::LbpB were
incubated with polyclonal antiserum specific for Mbp (New England
BioLabs), and the antiserum detected all three of the isolated proteins (data not shown), suggesting that the two smaller-molecular-mass proteins (95 and 85 kDa) were proteolytic breakdown products of Mbp::LbpB. Also, we prepared Western blots of total cellular
proteins from IPTG-induced E. coli
pMal-c2lbpB cells and incubated the blots with the
Mbp-specific polyclonal antiserum (Fig. 7, lane 7). The Mbp-specific
antiserum avidly detected the 123-kDa Mbp::LbpB, but we also
observed reactivity with a large number of proteolytic degradation
products (Fig. 7, lane 7).
Lf-binding activity following electroblotting has been demonstrated for
N. meningitidis (38) and M. catarrhalis (12) LbpB. We wanted to assess whether
recombinant LbpB also retained Lf-binding activity by using this
approach. Western blots of either the affinity-purified, unboiled
Mbp::LbpB (Fig. 7, lane 9) or unboiled, IPTG-induced E. coli pMal-c2lbpB whole cells (Fig. 7, lane 10) were
incubated with human Lf-HRP in low-stringency buffer. Human Lf-HRP was
found to bind avidly to all three of the amylose resin
affinity-isolated electroblotted proteins (Fig. 7, lane 9). In
addition, we observed avid Lf-HRP binding activity to a single protein
with an approximate molecular mass of 123 kDa from the IPTG-induced
E. coli pMal-c2lbpB whole cells (Fig. 7,
lane 10). In contrast, after SDS-PAGE and Western blotting, we were
unable to detect Lf binding to recombinant LbpB produced with the T7
system (with or without boiling) (data not shown). To assess the
stability of the Lf-binding domain of LbpB, we briefly boiled (1 to 2 min) the purified Mbp::LbpB in Laemmli sample buffer prior to
SDS-PAGE or Western blot analysis. No Lf-binding activity was detected
on the blots of the boiled Mbp::LbpB samples (data not shown). None
of the LbpA preparations displayed any Lf-binding activity after
SDS-PAGE and Western blotting (data not shown).
To evaluate the ligand-binding properties of the recombinant Lbps, we
performed solid-phase binding studies using either high- or
low-stringency conditions. These results were compared with the results
obtained with the solid-phase binding analysis with the meningococcal
isogenic mutants (Fig. 6). Our initial analysis consisted of utilizing
French press lysates of E. coli strains with
recombinant LbpA, LbpB, and Mbp::LbpB. As expected, E. coli cells producing LbpA (pT7lbpA) demonstrated avid
Lf-binding activity under either high- or low stringency-buffer
conditions (Fig. 8). E. coli cells producing LbpB (pT7lbpB) or Mbp::LbpB
(pMal-c2lbpB) displayed little Lf-binding activity under the
high-stringency buffer conditions (Fig. 8); however, under the
low-stringency buffer conditions, weak Lf-binding activity was detected
by the E. coli cells producing Mbp::LbpB (Fig. 8,
pMal-c2lbpB). Since these modified buffer conditions could
potentially foster interactions between Lf and E. coli
cell surface constituents (17), we wanted to ensure that the
Lf binding was specific. Therefore, we assessed the Lf-binding capacity
of amylose resin affinity-purified Mbp::LbpB by using the
low-stringency solid-phase assay system. Avid binding by the
recombinant fusion protein was detected (Fig. 8), and under these
conditions, there was no detectable binding by a control Mbp protein
(data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 8.
Analysis of binding of recombinant Lbps to Lf-HRP
conjugates with high- or low-stringency buffer. E. coli
DH5 cells producing recombinant LbpA, LbpB, or Mbp::LbpB were
grown to midlogarithmic phase in L broth and induced for production of
recombinant protein either by the addition of CE6 bacteriophage
(pT7lbpA and pT7lbpB) or by the addition of IPTG
(pMal-c2lbpB). The collected cells were lysed, and insoluble
cellular debris was removed by centrifugation. Lysed cell suspension or
amylose resin affinity-purified Mbp::LbpB was spotted onto the
nitrocellulose membranes. The membrane was blocked and then incubated
in either high-stringency binding buffer (50 mM Tris, 1 M NaCl [pH
9.0]) or low-stringency binding buffer (50 mM Tris, 0.1 M NaCl [pH
6.0]) containing 1:1,000 dilutions of peroxidase-conjugated human Lf
(HRP-hLf). The blots were washed in the respective binding buffer and
developed.
|
|
 |
DISCUSSION |
Analysis of previously described meningococcal (11, 37,
40) and gonococcal (9) LbpA
mutants
suggested that the bacterial Lf receptor had a single constituent. More
recently, biochemical and preliminary genetic evidence (10, 12,
36) suggested that the Lf receptor also has a B-component homolog
(LbpB). In addition, both this report and a recent publication by
Pettersson et al. (38) have identified a complete ORF
immediately upstream of the lbpA gene from N. meningitidis which encodes LbpB. In addition to having nearly
identical lbpB genes, strains BNCV (38) and B16B6
(this report) are of the same serotype, serogroup, and TbpB group
(42), suggesting that the two strains are from a similar
lineage.
Amino acid sequence comparisons of LbpB from N. meningitidis B16B6 with TbpB proteins from other related bacterial
species (Fig. 2) strongly suggest that the two proteins may serve as
functional homologs. Similarly, meningococcal outer membrane proteins
involved in iron acquisition from hemoglobin-haptoglobin (HpuA and
HpuB) are also likely composed of two antigenically distinct proteins (30). In these bipartite receptor systems, one component
(TbpA, LbpA, and HpuB) has regions of homology to other TonB-dependent receptors and likely has several regions which span the outer membrane,
allowing the protein to serve as a gated pore. In contrast, the second
component (TbpB, HpuA, and presumably LbpB) is an accessory lipoprotein, the role of which is not clearly defined. The N terminus of LbpB displays significant homologies to the N termini of
lipoproteins that are known to be posttranslationally modified by the
addition of fatty acyl chains to their N-terminal Cys residues before
cleavage by signal peptidase II (53), and TbpB lipidation
has been demonstrated previously (2, 18, 20, 29). Lipid
modification has been postulated to allow the protein to retain an
association with the outer membrane of the bacteria (29).
For N. meningitidis (29), N. gonorrhoeae (2), H. influenzae
(20), P. haemolytica (35), and
A. pleuropneumoniae (19), the tbpB
gene immediately precedes the tbpA gene in an operonic organization where the products of these genes are believed to be
cotranscribed during conditions of limiting iron (21). There are several lines of evidence that suggest that the N. meningitidis lbpB and lbpA genes appear to have similar
organizations. First, the cat
gene with an fd terminator
sequence inserted into the lbpB gene (approximately 1.4 kb
upstream of lbpA [Fig. 3]) abolishes LbpA production as
detected by Lf binding (Fig. 6). Second, growth using Lf as a sole iron
source was either abolished (lbpB::cat
) or
impaired (lbpB::gent) in these meningococcal
TbpA
TbpB
mutants (Table 2; see below).
Finally, analysis of the lbpB and lbpA ORFs
reveals that the TGA stop codon of the lbpB gene also
overlaps the predicted ATG start codon of the lbpA gene of the strain, suggesting that production of LbpB and LbpA is
translationally coupled. In contrast, tbpB and
tbpA genes are predicted to have an operonic organization
but have a variable intergenic region separating the two genes
which range from 14 bp (H. influenzae DL63
[20] and A. pleuropneumoniae H49
[19]) to 87 bp (N. meningitidis B16B6 [29]). Ultimately, mRNA transcript analysis of
the lbpB and lbpA genes will confirm this
hypothesis.
Although a Fur box consensus sequence in the purported lbpA
promoter region was previously reported (39), subsequent
studies have shown this to be incorrect (36). In support of
the hypothesis that both lbpB and lbpA genes are
transcribed in an iron-regulated operon, a Fur box with 16 of 19 bases
identical to those of the consensus sequences (5) and
overlapping the proposed
10 region was located upstream of the
lbpB gene from strains BNCV (38) and B16B6 (this
report). The fur gene product (Fur) described for
Neisseria spp. (8, 25) is likely to bind at this
site, although this remains to be experimentally validated. This
observation also correlates with the increased Lf-binding activity
(47) and enhanced LbpB and LbpA expression (38)
observed with N. meningitidis cells grown under
iron-limiting conditions.
In an attempt to characterize the proteins encoded by the N. meningitidis lbpA and lbpB ORFs, we placed the
structural genes under control of inducible promoters for heterologous
expression analysis in E. coli DH5
. We were able to
demonstrate that both the lbpA and lbpB ORFs
could be translated by using a heterologous promoter and expression
system in vitro (Fig. 7, pT7lbpA, pT7lbpB, and
pMal-c2lbpB). By using a solid-phase binding assay,
E. coli cells expressing recombinant LbpA (Fig. 7, lane
2) were shown to readily bind Lf under both high- and low-stringency
buffer conditions (Fig. 8). Although we were able to demonstrate
expression of recombinant LbpB from the T7 promoter (Fig. 7, lane 4),
we were unable to demonstrate that these cells had acquired the
capacity to bind Lf with the solid-phase binding assay using either
high- or low-stringency buffer conditions (Fig. 8). We suspected that the inability of recombinant LbpB produced in the T7 system to bind Lf
was due to improper folding and/or protein instability. Therefore, we
constructed an Mbp::LbpB fusion to overcome these limitations, as
described previously for meningococcal TbpB (41). We
detected weak Lf binding by E. coli cells expressing
Mbp::LbpB (Fig. 8, pMal-c2lbpB), whereas the
E. coli cells expressing Mbp alone (Fig. 8, pMal-c2)
were not able to bind Lf under either high- or low-stringency buffer
conditions. We also tested the amylose resin affinity-purified
Mbp::LbpB for Lf-binding activity and observed avid Lf-binding
activity under the low-stringency buffer conditions (Fig. 8); however,
no Lf-binding activity was detected by purified Mbp (data not shown).
To assess the stability of the Lf-binding domain of LbpA and LbpB, we
incubated the E. coli cells expressing LbpA, LbpB, or Mbp::LbpB with Laemmli sample buffer (with or without boiling) and
then subjected the samples to SDS-PAGE and Western blot analysis. Only
Mbp::LbpB was shown to bind Lf (Fig. 7, lane 10), suggesting that
recombinant Mbp::LbpB has a stable Lf-binding domain that is
retained even following SDS-PAGE and Western blotting. These results
are consistent with bacterial Tf receptors, in which the B constituent
is resistant to denaturation, and all Tf-binding activity of TbpA is
destroyed by even mild denaturation, suggesting a conformationally
dependent ligand-binding epitope(s). However, it is important to note
that the Lf-binding activity of LbpB was abolished when the samples
were boiled (data not shown), implying that the Lf-binding epitope of
LbpB may not be as stable as the Tf-binding epitope of TbpB. Similarly,
it has been recently demonstrated that insertional inactivation of the
lbpB ORF in the native organism was correlated with the loss
of a 95-kDa protein which displayed Lf-binding activity after SDS-PAGE
and Western blotting, providing the samples had not been boiled
(38).
The majority of isolated Mbp::LbpB had an approximate molecular
mass of 123 kDa (Fig. 7, lane 8); however, two additional proteins with
approximate molecular masses of 95 and 85 kDa (lane 8) were also
isolated. The ability of all three proteins to bind to amylose, and be
detected by Mbp-specific antisera, suggests that the two
smaller-molecular-mass proteins (95 and 85 kDa) were proteolytic
breakdown products of 123-kDa Mbp::LbpB in which regions of the C
terminus were removed. All three proteins bind Lf after Western
blotting (Fig. 7, lane 9), suggesting that a stable Lf-binding domain
is retained in the N-terminal region of LbpB. Similarly, the N-terminal
region of TbpB contains a stable Tf-binding domain (52).
To evaluate the role of LbpA and LbpB for in vitro iron acquisition
from Lf, we prepared a series of isogenic mutants lacking either or
both of the receptor proteins. For our analysis, iron-starved organisms
were spread on solid BHI growth media containing the iron chelator EDDA
and then sterile disks containing the individual iron sources were
placed on the media. As shown previously by ourselves (10)
and others (37, 40), meningococcal mutants lacking a
functional copy of the lbpA gene
(lbpA::cat
) were incapable of utilizing
human Lf as a sole iron source, suggesting that LbpA plays an essential
role (Table 2). In contrast, we observed zones of growth surrounding
the Lf-impregnated disks by the N. meningitidis mutant
lacking LbpB (lbpB::gent) (Table 2). Thus,
unlike meningococcal TbpB isogenic mutants, LbpB isogenic mutants
retain the ability to utilize human Lf as a sole iron source. Our
results suggest that LbpB plays a facilitative role for in vitro iron
acquisition, since the zone of growth surrounding the Lf-impregnated
disk was considerably smaller for the
lbpB::gent mutants, as compared to that for
the N16T12EK parental strain. Similar results have been reported for
N. gonorrhoeae (2) and H. influenzae (20) TbpB
mutants.
Lewis et al. suggest that the lipoprotein constituents of the Tf
receptor possess a phosphate-binding loop (P-loop motif) and may
contain adenine or guanine nucleotide binding sites (30). Presumptively, ATP or GTP hydrolysis at the outer membrane may occur at
some point to allow iron removal from the host iron-carrier protein
(30). Although this was not explicitly stated, the authors were presumably referring to the region of the M982 TbpB with the amino
acid sequence GDTNGKT (amino acids 469 to 475 of the mature protein).
One argument against this theory is the apparent lack of conservation
of the P-loop motif among TbpBs and LbpBs known to date (Fig. 2). In
addition, the M982 TbpB sequence does not contain the appropriate
number of amino acid residues associated with the P-loop motif
consensus sequence [GXXXXGK(TS)]. Further, it has been stated that
the P-loop motif consensus sequence with a large number of false
positives is found in many proteins (44).
Evidence of a B homolog for the Lf receptor (LbpB) with biochemical
attributes similar to that of TbpB has been documented for M. catarrhalis (10-12). However, M. catarrhalis appears to produce several Lf-binding proteins,
including LbpA, LbpB, and CopB (OMPB2), which directly or indirectly
play a role in iron acquisition from Lf (1, 12). Like the
M. catarrhalis OMPB1 (presumably TbpB) (10, 12,
13), the M. catarrhalis LbpB has a stable
ligand-binding epitope and displays Lf binding even after SDS-PAGE and
Western blotting (12), a property unique to TbpB-like
molecules (12, 18, 31, 46, 52). In addition, following
M. catarrhalis infection, a strong immune response to LbpB
occurs (12), suggesting that LbpB is expressed and
accessible to the immune system in vivo. Thus, LbpB may represent a
novel antigen for immunization purposes.
The availability of cloned lbpB and lbpA genes,
as well as specific isogenic mutants lacking these proteins, will
substantially aid in further characterization of these unique gene
products. Their individual roles in iron acquisition need further
evaluation, but based on prior models (21), it appears that
the Lf receptor system has numerous parallels to the Tf receptor
complex. The functional expression of these proteins in a heterologous
system will aid in production of significant quantities of these
proteins. Large amounts may be useful for vaccination purposes,
although it is evident that the problem of proteolytic degradation of
the recombinant protein may need to be addressed.
Lf is found in high concentrations on mucosal surfaces, and apo-Lf is
found in the granules of polymorphonuclear cells in vivo. Lf is
postulated to have several biological roles, including sequestration of
iron on mucosal surfaces (bacteriostatic effects). There is also
evidence that cationic peptides generated from proteolytic digestion of
the N-terminal region of Lf are involved in direct killing of bacteria
(bactericidal effects) at sites of infection (7, 16, 17). An
interesting feature of the putative amino acid sequence of the
N. meningitidis B16B6 LbpB protein is the two regions
of negatively charged amino acids. A speculative role for these regions
would be to bind to the Lf-derived cationic peptides (7),
thus preventing the bactericidal effects exhibited when these peptides
bind to Lipid A (3) and disrupt the integrity of the outer
membrane (16). Cornelissen et al. have recently reported
that without Tf receptors, N. gonorrhoeae FA1090 was unable to colonize human male volunteers in an experimental urethritis model (14). It is important to note that these mutants also lacked the ability to utilize human Lf (undefined mutation), and it is
unknown if these mutants produce LbpB. This may be an important consideration, since LbpB may play a role in preventing the
bactericidal effects of Lf and peptides derived from Lf.
Lf receptors are not ubiquitous among organisms having Tf receptors.
Although members of the family Neisseriaceae are able to
utilize both Tf and Lf as a sole iron source, (10) members of the related family Pasteurellaceae produce host-specific
Tf receptors but none have been shown to produce Lf receptors. Due to
the similar genetic organization of tbpBA and
lbpBA genes, it is likely the lbpBA genes
disseminated from duplication of the tbpBA genes after
divergence of the Pasteurellaceae and
Neisseriaceae. In addition, disease isolates producing only
Lf receptors have not been reported to date. Thus, Lbps may be less
evolved and, consequently, less antigenically diverse than Tbps and
could represent a more conserved vaccine target. However, should a
disseminated organism lose the ability to produce Lf receptors, it is
unknown whether this would affect further growth since Tf is likely to be a prominent iron source. Thus, studies aimed at determining both the
antigenic heterogeneity and ubiquity of LbpBs among disease isolates
are of considerable interest and should be pursued.
 |
ACKNOWLEDGMENTS |
This work was supported by the Medical Research Council of Canada
grant MT10350.
We thank Rainer Haas for his helpful E-mail discussions and for
providing plasmid pTnMax4 and Annika Pettersson and Jan Tommassen for
provision of plasmid pAM23 and for their useful comments. We also
acknowledge Henry Wong for his technical assistance in preparing the
cloned cat
cassette with flanking SalI sites.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Infectious Diseases, University of Calgary, Heritage Medical Research Bldg., Health Sciences Center, Calgary, Alberta, Canada T2N 4N1. Phone: (403) 220-3703. Fax: (403) 270-2772. E-mail: schryver{at}acs.ucalgary.ca.
 |
REFERENCES |
| 1.
|
Aebi, C.,
B. Stone,
M. Beucher,
L. D. Cope,
I. Maciver,
S. E. Thomas,
G. H. McCracken, Jr.,
P. F. Sparling, and E. J. Hansen.
1996.
Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin.
Infect. Immun.
64:2024-2030[Abstract].
|
| 2.
|
Anderson, J. A.,
P. F. Sparling, and C. N. Cornelissen.
1994.
Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization.
J. Bacteriol.
176:3162-3170[Abstract/Free Full Text].
|
| 3.
|
Appelmelk, B. J.,
Y.-Q. An,
M. Geerts,
B. G. Thijs,
H. A. De Boer,
D. M. Maclaren,
J. De Graaff, and J. H. Nuijens.
1994.
Lactoferrin is a lipid A-binding protein.
Infect. Immun.
62:2628-2632[Abstract/Free Full Text].
|
| 4.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1989.
In
Current protocols in molecular biology.
John Wiley & Sons, Inc., New York, N.Y.
|
| 5.
|
Bagg, A., and J. B. Neilands.
1987.
Molecular mechanisms of regulation of siderophore-mediated iron assimilation.
Microbiol. Rev.
51:509-518[Free Full Text].
|
| 6.
|
Barcak, G. J.,
M. S. Chandler,
R. J. Redfield, and J.-F. Tomb.
1991.
Genetic systems in Haemophilus influenzae.
Methods Enzymol.
204:321-342[Medline].
|
| 7.
|
Bellamy, W.,
M. Takase,
K. Yamauchi,
H. Wakabayashi,
K. Kawase, and M. Tomita.
1992.
Identification of the bactericial domain of lactoferrin.
Biochim. Biophys. Acta
1121:130-136[Medline].
|
| 8.
|
Berish, S. A.,
S. Subbarao,
C.-Y. Chen,
D. L. Trees, and S. A. Morse.
1993.
Identification and cloning of a fur homolog from Neisseria gonorrhoeae.
Infect. Immun.
61:4599-4606[Abstract/Free Full Text].
|
| 9.
|
Biswas, G. D., and P. F. Sparling.
1995.
Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae.
Infect. Immun.
63:2958-2967[Abstract].
|
| 10.
|
Bonnah, R. A.,
R.-H. Yu, and A. B. Schryvers.
1995.
Biochemical analysis of lactoferrin receptors in the Neisseriaceae: identification of a second bacterial lactoferrin receptor protein.
Microb. Pathog.
19:285-297[Medline].
|
| 11.
|
Bonnah, R. A.,
R.-H. Yu, and A. B. Schryvers.
1997.
Bacterial lactoferrin receptors in the Neisseriaceae, p. 277-301.
In
B. Lonnerdol, and W. Hutchens (ed.), Lactoferrin: interactions and biological functions. Humana Press, Totowa, N.J.
|
| 12.
|
Bonnah, R. A.,
R.-H. Yu,
H. Wong, and A. B. Schryvers.
1998.
Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis.
Microb. Pathog.
24:89-100[Medline].
|
| 13.
|
Campagnari, A. A.,
T. F. Ducey, and C. A. Rebmann.
1996.
Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin.
Infect. Immun.
64:3920-3924[Abstract].
|
| 14.
|
Cornelissen, C. N.,
M. Kelley,
M. M. Hobbs,
J. E. Anderson,
J. G. Cannon,
M. S. Cohen, and P. F. Sparling.
1998.
The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers.
Mol. Microbiol.
27:611-616[Medline].
|
| 15.
|
Crosa, J. H.
1989.
Genetics and molecular biology of siderophore-mediated iron transport in bacteria.
Microbiol. Lett.
53:517-530.
|
| 16.
|
Ellison, R. T., III, and T. J. Giehl.
1991.
Killing of gram-negative bacteria by lactoferrin and lysozyme.
J. Clin. Invest.
88:1080-1091.
|
| 17.
|
Ellison, R. T., III,
F. M. LaForce,
T. J. Giehl,
D. S. Boose, and B. E. Dunn.
1990.
Lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca2+ and Mg2+.
J. Gen. Microbiol.
136:1437-1446[Medline].
|
| 18.
|
Gerlach, G. F.,
C. Anderson,
A. A. Potter,
S. Klashinsky, and P. J. Willson.
1992.
Cloning and expression of a transferrin-binding protein from Actinobacillus pleuropneumoniae.
Infect. Immun.
60:892-898[Abstract/Free Full Text].
|
| 19.
|
Gonzalez, G. C.,
R.-H. Yu,
P. Rosteck, and A. B. Schryvers.
1995.
Sequence, genetic analysis, and expression of Actinobacillus pleuropneumoniae transferrin receptor genes.
Microbiology
141:2405-2416[Abstract].
|
| 20.
|
Gray-Owen, S. D.,
S. Loosmore, and A. B. Schryvers.
1995.
Identification and characterization of genes encoding the human transferrin-binding proteins from Haemophilus influenzae.
Infect. Immun.
63:1201-1210[Abstract].
|
| 21.
|
Gray-Owen, S. D., and A. B. Schryvers.
1996.
Bacterial transferrin and lactoferrin receptors.
Trends Microbiol.
4:185-191[Medline].
|
| 22.
|
Haas, R.,
A. F. Kahrs,
D. Facius,
H. Allmeier,
R. Schmitt, and T. F. Meyer.
1993.
TnMax a versatile mini-transposon for the analysis of cloned genes and shuttle mutagenesis.
Gene
130:23-31[Medline].
|
| 23.
|
Hawley, D. K., and W. R. McClure.
1983.
Compilation and analysis of Escherichia coli promoter DNA sequences.
Nucleic Acids Res.
11:2237-2255[Abstract/Free Full Text].
|
| 24.
|
Irwin, S. W.,
N. Averill,
C. Y. Cheng, and A. B. Schryvers.
1993.
Preparation and analysis of isogenic mutants in the transferrin receptor protein genes, tbp1 and tbp2, from Neisseria meningitidis.
Mol. Microbiol.
8:1125-1133[Medline].
|
| 25.
|
Karkhoff-Schweizer, R. R.,
A. B. Schryvers, and H. P. Schweizer.
1994.
Cloning and sequence analysis of the fur gene encoding an iron-regulatory protein of Neisseria meningitidis.
Gene
141:139-140[Medline].
|
| 26.
|
Khun, H. H.,
S. D. Kirby, and B. C. Lee.
1998.
A Neisseria meningitidis fbpABC mutant is incapable of using nonheme iron for growth.
Infect. Immun.
66:2330-2336[Abstract/Free Full Text].
|
| 27.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
|